MPH Health Care

Earnings Release • Mar 8, 2012

News Details

Corporate | 8 March 2012 08:00

MPH Mittelständische Pharma Holding AG:

MPH Mittelständische Pharma Holding AG / Key word(s): Final Results/Preliminary Results

08.03.2012 / 08:00

---

MPH Mittelständische Pharma Holding AG:

Preliminary result year 2011

Compared to the previous year the turnover increased in year 2011 by +29.4% and reached 145.51m Euro. The net profit was 8.65m Euro.

A net profit/share of 23 Cent was earned. The Management Board proposes a dividend payment of 20 Cent/preference share.

The company MPH Mittelständische Pharma Holding AG today presents the preliminary results for year 2011.

MPH group achieved a turnover to the amount of 145.51m Euro (prior year 112.41m Euro) and a net profit to the amount of 8.65m Euro (prior year 9.12m Euro).

In Germany the mandatory manufacturer discount related to patent-protected non-reference price drugs was increased in August 2010 from 6 % to 16 %. These legislatively prescribed price interventions apply for a limited period of time up to the year 2013, and significantly degrade the result situation of the pharmaceutical companies. In spite of the increase of the mandatory manufacturer discount by 10%, valid for the full year 2011, the net yield only decreased from 8.12% to 5.94% annual profit. The MPH group is counteracting the regulatory challenges with an extension of the product portfolio and through the development of new business markets.

For the current business year 2012 the MPH group is estimating a turnover growth as in the previous year, and a net yield also as in the previous year.

About the company MPH Mittelständische Pharma Holding AG:

The Berlin based company MPH Mittelständische Pharma Holding AG has strategically concentrated its activities on growth segments in the pharmaceutical market. With pharmaceutical products based on patent-free and patent-protected active substances, which are made available through the MPH group in the therapeutic areas oncology, HIV, rheumatology, neurology and cardiovascular diseases, a contribution is made towards cost reduction in the healthcare sector.

MPH Mittelständische Pharma Holding AG has been listed on the stock exchange (Open Market) in Frankfurt as of September, 1, 2009. An application for listing in the Entry Standard was filed.

Key capital market data for MPH Mittelständische Pharma Holding AG:

Subscribed Capital: EUR 38.050.000

Stock exchange listed class of shares: Owner held-preferred shares

Number of circulating preference shares: 19.025.000

ISIN: DE000A0NF697

WKN: A0NF69

Stock Exchange code: 93MV

End of Corporate News

---

08.03.2012 Dissemination of a Corporate News, transmitted by DGAP – a company of EquityStory AG.

The issuer is solely responsible for the content of this announcement.

DGAP’s Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Media archive at www.dgap-medientreff.de and www.dgap.de

---

159748  08.03.2012